Phillips-Medisize Corporation announced a 60,000 square foot (6,000 square meter) expansion to their Kontiolahti, Finland site. This site focuses on the production of complex drug delivery devices such as inhalers, injection pens and safety syringes. This state-of-the-art facility manufactures various products from multi component drug delivery devices in prototype form to finished drug delivery devices in a high speed automated production environment.
This expansion was driven by new opportunities that Phillips-Medisize has been awarded over the past 12 months, as well as, to support increased global demand for devices with precise dosage drug delivery requirements that the company currently manufactures at the Kontiolahti site.
Source: www.phillipsplastics.com
